Nuzenio

Aft Pharmaceuticals Re

Aft Pharmaceuticals Re news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Sun, 02 Aug 2026 17:00:00 GMTSmall NZ drugmaker quietly outperforms global giants Pfizer and Merck - newsroom.co.nz
Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Shareholders Re-Elect Marree Atkinson With 99.98% Support at 2026 Annual Meeting - Kalkine
Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Re-Elects Director Marree Atkinson with 99.98% Vote at 2026 AGM - Kalkine Media
Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Reports 22% Revenue Growth to $254.7 Million, Lifts Dividend to 2.5 Cents - Kalkine
Thu, 30 Jul 2026 22:12:09 GMTAFT: 22% sales growth, 39% higher dividend, and global expansion drive FY26 performance - TradingView
Wed, 29 Jul 2026 07:00:00 GMTAFT Pharmaceuticals eyes 'multi-billion-dollar markets' for products still in development - RNZ

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Aft Pharmaceuticals Re.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.